"The Missouri Memory Center (MMC) features a multi-disciplinary team, led by board certified neurologist Curtis P. Schreiber, M.D., who are experts in diagnosing and treating patients with memory problems related to dementia, Alzheimer’s disease and other neuropsychological issues."

During the past decade, Missouri Memory Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Missouri Memory Center" are "Alzheimer Disease" (3 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Missouri Memory Center" in a lesser frequency.

Most popular intervention types in "Missouri Memory Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Gantenerumab" (2 trials), "Donanemab" (1 trials) and "LY3202626" (1 trials). Other intervention names were less common.

The vast majority of trials in "Missouri Memory Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Missouri Memory Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Missouri Memory Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Missouri Memory Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".